Study of Low-Dose Cytarabine in Combination With Arsenic Trioxide, Compared With Low-Dose Cytarabine Alone, for the Treatment of Elderly Patients With Acute Myeloid Leukemia

This study is currently recruiting participants.
Information provided by Cephalon

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Acute Myeloid Leukemia
2		Additional conditions recognized in this trial
			Leukemia
			Leukemia, Myeloid
			Leukemia, Myeloid, Acute
3		More general conditions related to this trial
			Neoplasms
			Neoplasms by Histologic Type
4		Additional drug interventions recognized in this trial
			Arsenic trioxide
			Cytarabine
5		More general drug interventions related to this trial
			Anti-Infective Agents
			Antimetabolites
			Antimetabolites, Antineoplastic
			Antineoplastic Agents
			Antiviral Agents
			Immunologic Factors
			Immunosuppressive Agents
			Molecular Mechanisms of Pharmacological Action
			Pharmacologic Actions
			Physiological Effects of Drugs
			Therapeutic Uses
6		Sponsors listed in this trial
			Cephalon